Page last updated: 2024-08-25

bexarotene and ACTH-Producing Pituitary Adenoma

bexarotene has been researched along with ACTH-Producing Pituitary Adenoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Chen, Y; Li, G; Lu, J; Shen, D; Wang, H; Wang, M; Xia, L; Xie, D; Xue, D; Zhang, Y	1

Other Studies

1 other study(ies) available for bexarotene and ACTH-Producing Pituitary Adenoma

Article	Year
Targeting the TR4 nuclear receptor with antagonist bexarotene can suppress the proopiomelanocortin signalling in AtT-20 cells. Journal of cellular and molecular medicine, 2021, Volume: 25, Issue:5 Topics: ACTH-Secreting Pituitary Adenoma; Adrenocorticotropic Hormone; Animals; Bexarotene; Binding Sites; Cell Line, Tumor; Disease Models, Animal; Drug Discovery; Gene Expression; Humans; Mice; Models, Molecular; Molecular Conformation; Nuclear Receptor Subfamily 2, Group C, Member 2; Pituitary ACTH Hypersecretion; Pro-Opiomelanocortin; Protein Binding; Protein Transport; Signal Transduction; Structure-Activity Relationship; Transcription, Genetic; Xenograft Model Antitumor Assays	2021

Article

Year

Targeting the TR4 nuclear receptor with antagonist bexarotene can suppress the proopiomelanocortin signalling in AtT-20 cells.

Journal of cellular and molecular medicine, 2021, Volume: 25, Issue:5

Topics: ACTH-Secreting Pituitary Adenoma; Adrenocorticotropic Hormone; Animals; Bexarotene; Binding Sites; Cell Line, Tumor; Disease Models, Animal; Drug Discovery; Gene Expression; Humans; Mice; Models, Molecular; Molecular Conformation; Nuclear Receptor Subfamily 2, Group C, Member 2; Pituitary ACTH Hypersecretion; Pro-Opiomelanocortin; Protein Binding; Protein Transport; Signal Transduction; Structure-Activity Relationship; Transcription, Genetic; Xenograft Model Antitumor Assays

2021